NASDAQ:CRBP

Corbus Pharmaceuticals Holdings Stock Predictions

etoro logo Buy CRBP
*Your capital is at risk
$7.38
-0.160 (-2.12%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CRBP Prediction Chart

CRBP Predictions History

Latest community submissions for CRBP.
Predictor Target Session Target Price Result Direction Accuracy Score
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Aug 11, 2020 $8.08 -96.13% $6.96 X 83.91% 1
JS JS Pro
Aug 10, 2020 $6.70 -96.75% $6.87 X 97.53% 1
2poJeff 2poJeff Pro
Aug 10, 2020 $6.41 -96.89% $6.87 X 93.30% 1
Dec 26, 2019 Bullish $5.64 X 1
May 7, 2019 $7.47 -96.58% $7.29 V 97.49% 0
May 6, 2019 $7.17 -96.80% $7.46 V 96.11% 0
Apr 10, 2019 $7.28 -96.54% $7.01 X 96.15% 0
Mar 21, 2019 $7.47 -96.76% $7.68 X 97.30% 0
Gp Gp Merchant @Gp.98898
Mar 18, 2019 $7.11 -96.55% $6.87 X 96.50% 0
Mar 18, 2019 $8.41 -95.92% $6.87 X 77.60% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CRBP with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CORBUS PHARMACEUTICALS HOLDINGS
Corbus Pharmaceuticals Holdings
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE